Navigating the complexities of fibromyalgia research: an artificial intelligence-driven exploration

Introduction

Fibromyalgia, a multifaceted chronic condition characterized by widespread pain, fatigue, cognitive disturbances, and a variety of somatic symptoms, has been the subject of medical scrutiny and research for several decades. Despite the profound impact of fibromyalgia on the lives of millions worldwide, it remains a clinical conundrum, challenging both patients and healthcare providers alike (1). The intricate web of factors contributing to its pathophysiology, coupled with the diversity of clinical presentations among individuals, renders fibromyalgia an intricate puzzle that continues to elude a comprehensive understanding.

The 21st century has witnessed an unprecedented surge in the generation and availability of healthcare data, largely due to the digitization of medical records, advancements in medical imaging, and the proliferation of wearable devices that continuously monitor physiological parameters. This data deluge has ushered in a new era in medical research, where the power of big data analytics presents unparalleled opportunities for unraveling complex medical mysteries (2).

In the context of fibromyalgia, big data analytics offers a transformative lens through which to examine the trajectory of research surrounding this condition. It provides an avenue to dissect and decipher the evolving narrative of fibromyalgia study, shedding light on shifts in research focus, methodologies, and treatment paradigms. This pioneering study’s primary objective is to harness big data analytics’ capabilities to trace the evolution of fibromyalgia research meticulously.

This exploration is achieved by meticulously analyzing a vast corpus of academic abstracts sourced from PubMed, a repository of biomedical literature. By scrutinizing these abstracts, we endeavor to discern key research trends, identify recurrently explored subtopics, and pinpoint noteworthy transitions in treatment approaches within fibromyalgia research. Such an approach mirrors the burgeoning acknowledgment of the immense value of big data in healthcare research, where data-driven insights are poised to catalyze more informed decision- making and ultimately enhance patient outcomes (3).

The significance of this study is further underscored by the escalating prevalence of fibromyalgia globally and the ongoing quest for efficacious management strategies. This investigation contributes substantially to the broader comprehension of the multifaceted fibromyalgia landscape by providing a meticulous and holistic analysis of research trends. This study highlights areas that require further exploration and detailed investigation, providing for improved understanding and more effective interventions for those grappling with the complex challenges posed by fibromyalgia.

Emergence of big data in medical research

The emergence of big data in medical research represents a transformative paradigm shift. This shift is characterized by utilizing massive datasets with high volume, variety, and velocity to extract meaningful insights and improve healthcare outcomes (2).

In the context of fibromyalgia research, the incorporation of big data has revolutionized the approach to understanding the condition. Traditional research methods relied on relatively small-scale studies with limited sample sizes. Big data analytics, however, enables the analysis of extensive datasets comprising information from diverse sources, such as patient records, clinical trials, genetic data, and patient-reported outcomes.

One of the primary advantages of big data in fibromyalgia research is its ability to uncover intricate patterns and associations previously inaccessible through conventional methods (4). With the accumulation of vast amounts of data related to fibromyalgia patients, their symptoms, treatment responses, and genetic profiles, researchers can now explore the condition in unprecedented detail.

This shift toward big data has facilitated a more nuanced understanding of fibromyalgia’s epidemiology, pathophysiology, and treatment responses (4). It has allowed researchers to delve deeper into the multifaceted nature of the condition, enabling them to identify potential subgroups of patients and tailor treatment approaches accordingly.

In summary, the historical evolution of fibromyalgia research has progressed from initial misunderstandings and psychological attributions to a more comprehensive recognition of its multifactorial nature. The emergence of big data has further accelerated this progress, providing researchers with the tools and resources to unravel the complexities of fibromyalgia and explore novel avenues for improving patient care.

Methods

Our analysis utilizes a dataset comprising 5,861 fibromyalgia-related abstracts from PubMed, publicly available on Kaggle (5). This dataset represents a comprehensive aggregation of fibromyalgia studies, providing a diverse and rich source of information for our analysis. The election represents a diverse range of research published from 1982 to 2020, covering a broad spectrum of subtopics within the field of fibromyalgia. The dataset was subjected to a rigorous preprocessing regimen involving normalization, tokenization, and the removal of stop-words to ensure consistency and relevance in the analysis. Subsequent analytical procedures included keyword frequency analysis, Latent Dirichlet Allocation (LDA) for topic modelling, and sentiment analysis, each contributing unique insights into the trends and shifts in fibromyalgia research. This methodological approach was chosen for its ability to distil large volumes of textual data into understandable patterns and themes, facilitating a nuanced understanding of the evolving research landscape.

Statistical analysis

Our study utilized a variety of statistical methods to ensure a comprehensive and rigorous analysis of the fibromyalgia-related abstracts dataset. This section details the statistical techniques applied, including preprocessing, keyword frequency analysis, topic modelling, sentiment analysis, and significance testing.

Descriptive statistics

The dataset of 5,861 fibromyalgia-related abstracts was analyzed to provide an overview of the textual content summarized in Table 1.

Data preprocessing

To ensure consistency and relevance in the analysis, the dataset underwent a rigorous preprocessing regimen. This involved the following steps:

• Normalization: text normalization was performed to convert all text to lowercase, remove punctuation, and standardize terms;
• Tokenization: the abstracts were tokenized into individual words or terms to facilitate analysis;
• Stop-word removal: common stop-words (e.g., “and”, “the”, “of”) were removed to focus on meaningful terms;
• Stemming: words were reduced to their base or root forms to consolidate different forms of the same word.

Keyword frequency analysis

A keyword frequency analysis was conducted to identify the most frequently occurring terms within the dataset. This analysis involved:

• Term frequency calculation: the frequency of each term was calculated across all abstracts to identify the most frequent terms;
• Visualization: word clouds and bar charts were created to visually represent the most frequent terms and their relative frequencies, highlighting the primary focus areas in fibromyalgia research.

LDA for topic modelling

LDA was employed to uncover distinct thematic clusters within the abstracts. LDA is a generative statistical model that allows sets of observations to be explained by unobserved groups, identifying topics that best describe a collection of documents. The process involved:

• Topics selection: we used coherence scores to determine the optimal number of topics, ensuring that the chosen number provides a balance between interpretability and granularity;
• Model training: the LDA model was trained on the pre-processed dataset to identify key topics and their associated terms;
• Topic interpretation: each topic was interpreted based on the top contributing words, allowing us to understand the primary research areas within fibromyalgia studies.

Sentiment analysis

Sentiment analysis was performed to gauge the overall tone of the fibromyalgia research abstracts. Using a sentiment analysis model implemented through the Scikit-Learn library, each abstract was assigned a sentiment score. The scores ranged from −1 (negative sentiment) to +1 (positive sentiment), with 0 indicating neutral sentiment. The sentiment scores were categorized into positive, neutral, and negative sentiment groups, providing insights into the general outlook of the research community towards fibromyalgia research.

Statistical validation

To validate the findings from our analyses, we applied statistical tests and validation techniques as follows:

• Cross-validation techniques were used to ensure the robustness and reliability of the LDA model. This involved splitting the dataset into training and validation sets to test the model’s performance.
• Significance testing was performed on key findings to determine their statistical validity. For example, the prominence of certain keywords and the sentiment scores were tested for statistical significance using appropriate tests like t-tests, and chi-square tests.

Tools and libraries

Our analysis was conducted using Python 3, leveraging several powerful libraries renowned for their efficacy in data processing and analysis:

• Pandas: for data manipulation and analysis;
• Natural Language Toolkit (NLTK): used for text processing tasks such as tokenization, stop-words removal, and stemming;
• Genism: for implementing topic modelling using LDA;
• Matplotlib and Seaborn: for creating data visualizations, including word clouds, bar charts, line graphs, and stacked area charts;
• Scikit-Learn: for implementing sentiment analysis models.

Results

Our comprehensive analysis of the dataset consisting of fibromyalgia abstracts yielded valuable insights into the evolving landscape of fibromyalgia research. Examining these abstracts provided a detailed snapshot of the most commonly discussed topics and themes within the field, shedding light on the dynamic nature of fibromyalgia research over time.

Word cloud of key terms

A word cloud, as shown in Figure 1, was generated to represent the frequency of keywords in the fibromyalgia abstracts visually. The word cloud provides a visual representation of the most frequently occurring terms in the fibromyalgia research abstracts, highlighting the primary focus areas such as patient-centric research and pain management. Notably, the word ‘patient’ stood out prominently, followed by ‘fm’ (an abbreviation for fibromyalgia), ‘pain’, ‘fibromyalgia’, and ‘study’. This visualization not only underscores the patient-centric nature of the research but also highlights the focus areas, such as pain management and clinical studies in fibromyalgia.

Figure 1 Word cloud of key terms in fibromyalgia research.

Frequency of key terms

A bar chart, presented in Figure 2, provides a clear quantitative view of the most discussed topics in the research. In our investigation, we observed that specific terms appeared with remarkable frequency in the abstracts, signifying their significance in the context of fibromyalgia research. The most prominently recurring terms included ‘patient’, ‘FM’ (fibromyalgia), ‘pain’, ‘study’, ‘group’, ‘p’ (likely referring to statistical significance), ‘symptom’, ‘treatment’, and ‘control’. These terms not only underscored the central themes of fibromyalgia research but also highlighted the research community’s emphasis on understanding and managing the multifaceted nature of fibromyalgia, particularly the physical and psychological burden it places on patients. The frequency of the term ‘patient’ being the most prominent underscores a noticeable shift towards a patient-centric approach in recent fibromyalgia studies. This aligns with contemporary trends in healthcare research that emphasize patient-reported outcomes and patient-centric care models (6).

Figure 2 Word frequency of critical terms in fibromyalgia research.

Trends in research focus over time

A line graph (Figure 3) depicting the number of publications per year was plotted to analyze the evolution of fibromyalgia research over time. The data from the early 1980s to recent years indicates periods of intensified research activity and epochs where the volume of published work has tapered off.

Figure 3 Trend chart for fibromyalgia research.

From the late 1990s through the early 2000s, there is a noticeable uptick in publication frequency, possibly reflecting burgeoning interest in fibromyalgia and its impact on population health. This could correlate with the increased recognition of fibromyalgia as a distinct clinical entity and the concurrent development of diagnostic criteria, which may have spurred research efforts.

A pronounced peak was observed in the late 2000s, which might correspond with a global emphasis on chronic pain management and the availability of new research funding streams. This peak also aligns with technological advancements in data processing and healthcare analytics, enabling more sophisticated and large-scale studies.

The early to mid-2010s show a slight decline in publication numbers, which may suggest a plateau in research breakthroughs or a shift in scientific focus to other emerging health issues. It’s also possible that this reflects a period of consolidation, where the research community may have focused on evaluating the implications of prior discoveries and integrating them into clinical practice.

Most recently, there appears to be a resurgence in publication volume, which could be attributed to the integration of AI and big data analytics in medical research, as mentioned in the study’s abstract. This resurgence is likely driven by the potential of these technologies to unlock new insights into complex conditions like fibromyalgia through the analysis of large datasets, signalling a new horizon in the field’s evolution.

Topic analysis

Our study employed LDA to uncover distinct thematic clusters within the vast corpus of fibromyalgia research abstracts. The LDA analysis revealed five prominent topics, each representing a unique aspect of the ongoing research in fibromyalgia:

• Treatment efficacy and sleep-related studies: the first topic is characterized by a significant emphasis on ‘treatment’ (0.022) and ‘sleep’ (0.015), along with notable mentions of ‘placebo’ (0.011) and ‘studies’ (0.011). This suggests a focus on the evaluation of treatment effectiveness, particularly in the context of sleep disturbances associated with fibromyalgia. The term ‘placebo’ indicates a methodological approach where the efficacy of active treatments is often compared against placebo controls in clinical trials.
• Physical therapy and exercise regimens: the second topic highlights the importance of ‘physical’ therapy (0.011) and ‘exercise’ (0.011) in fibromyalgia management, alongside ‘treatment’ (0.013) and ‘group’ (0.011). This theme underscores the growing recognition of non-pharmacological interventions in fibromyalgia, particularly physical exercise and group-based therapies, in alleviating symptoms and improving the quality of life for patients.
• Symptoms, syndrome classification, and chronicity: the third topic is dominated by terms like ‘symptoms’ (0.014), ‘syndrome’ (0.013), ‘criteria’ (0.011), and ‘chronic’ (0.011). This reflects a research focus on the symptomatology of fibromyalgia, its classification as a syndrome, and the chronic nature of the condition. The mention of ‘criteria’ likely relates to diagnostic criteria and the ongoing efforts to refine and standardize the diagnosis of fibromyalgia.
• Comparative studies with controls: the fourth topic, featuring terms such as ‘controls’ (0.010), ‘fms’ (fibromyalgia syndrome, 0.010), ‘muscle’ (0.009), and ‘healthy’ (0.008), suggests a research trend where fibromyalgia patients are often compared with healthy controls. This likely includes studies examining muscle physiology and other biomarkers to differentiate fibromyalgia patients from healthy individuals, enhancing our understanding of the underlying pathophysiological mechanisms.
• Gender-specific research and outcome measurement: the fifth topic is marked by the prevalence of ‘group’ (0.015), with a specific focus on ‘women’ (0.012), and the use of various ‘scores’ and ‘scale’ (both 0.011). This points to the gender-specific aspects of fibromyalgia research, acknowledging that women are disproportionately affected by the condition. The presence of terms related to scoring and scales indicates a strong emphasis on quantifying symptoms and outcomes, which is essential for assessing the impact of fibromyalgia and the effectiveness of treatments.

As shown in Figure 4, one of the most striking observations from the heatmap is the variation in the significance of terms across different topics. For instance, ‘treatment’ appears as a prominent term in both topic 1 and topic 2, but with varying degrees of emphasis. This variation suggests that while treatment is a central theme in fibromyalgia research, its specific focus can differ significantly, ranging from general treatment efficacy to specific modalities like physical therapy and exercise.

Figure 4 Heat map for fibromyalgia research. LDA, Latent Dirichlet Allocation.

The insights gained from the heatmap can guide future research endeavors. For instance, areas with less color intensity might represent underexplored themes that could benefit from additional research. This understanding can help researchers and funding bodies prioritize certain areas or approaches in future fibromyalgia studies.

In addition to identifying shifts in research focus, our analysis illuminated several emerging subtopics within the domain of fibromyalgia research:

• Neurological basis of fibromyalgia: the frequent appearance of ‘pain’ in the abstracts correlates with an increasing focus on the neurological aspects of fibromyalgia pain (7). This includes studies on the central sensitization syndrome, where the central nervous system plays a key role in pain perception. Researchers are delving deeper into the neural pathways and processes involved in fibromyalgia, offering hope for more targeted therapeutic interventions. For example, recent advancements, such as the work by Jiang et al. (8), have demonstrated the efficacy of machine learning algorithms in predicting central sensitization in fibromyalgia patients, signifying a promising direction for enhanced diagnosis and treatment planning.
• Statistical analysis in fibromyalgia studies: the dataset’s recurrence of ‘p’ indicates a robust statistical approach in recent studies, underscoring the importance of quantitative analysis in understanding fibromyalgia. This trend reflects the growing sophistication of research methodologies in the field (9). Researchers are employing advanced statistical techniques to enhance the precision and reliability of their findings, a crucial step in advancing our understanding of the condition.
• Comparative studies and control groups: the frequent appearance of ‘group’ and ‘control’ points to the prevalence of comparative studies, possibly reflecting randomized controlled trials (RCTs) and comparative effectiveness research in fibromyalgia (10). This trend underscores the emphasis on establishing evidence-based treatments and interventions. Researchers rigorously compare various treatment modalities, aiming to identify the most effective approaches for managing fibromyalgia and improving patients’ quality of life.

Sentiment analysis

The sentiment analysis of the abstracts revealed an overall positive sentiment, with an average sentiment score of approximately 0.078. This slightly positive inclination of the sentiment score suggests a cautiously optimistic tone within the research community regarding advancements in understanding and managing fibromyalgia. Specifically, as shown in Figure 5, the sentiment distribution is provided below:

• Positive sentiment: 42%;
• Neutral sentiment: 35%;
• Negative sentiment: 23%.

Figure 5 Overall sentiment analysis results.

The key findings from the thematic and sentiment analyses are summarized in Table 2, which highlights the major research trends and their potential implications in the fibromyalgia literature.

Statistical validation

The following statistical validation steps were performed to ensure the robustness and reliability of our findings:

• Cross-validation of LDA model: the LDA model’s coherence score was 0.52, indicating an optimal number of five topics and ensuring a balance between interpretability and granularity;
• Significance testing: Chi-squared tests were conducted to determine if the frequency of certain keywords and sentiment scores were significantly different from what would be expected by chance. The results showed a P value of <0.05, confirming that the observed patterns were statistically significant. This contributes to the body of evidence-based research in the field of fibromyalgia, indicating genuine areas of focus within the research community and guiding future research and funding priorities.

Discussion

The findings of our study shed light on the evolving landscape of fibromyalgia research, with implications for both clinical practice and future scientific inquiry. The analysis of keyword frequencies revealed a noteworthy shift in research focus over time, transitioning from a predominantly symptomatic approach towards a more mechanistic understanding of fibromyalgia. This shift aligns with the broader trend in medical research, which recognizes the importance of unraveling the underlying mechanisms of chronic conditions.

In line with our findings, Smith et al. (11) have explored the impact of big data analytics in chronic pain management, showcasing its potential in developing personalized medicine approaches for conditions like fibromyalgia. Moreover, the emphasis on patient-centric research, as indicated by the prominence of the term ‘patient’, underscores a growing recognition of the significance of patient-reported outcomes and the need for personalized care models. This approach reflects a positive trend towards tailoring treatments to individual patients, acknowledging the heterogeneity of fibromyalgia presentations. However, while the rise in patient-centric language is evident in the abstracts, it remains unclear whether this rhetorical shift translates into measurable improvements in patient-reported outcomes or quality of care—an area that merits closer empirical scrutiny.

The emergence of subtopics, such as the neurological basis of fibromyalgia and the prevalence of statistical analysis and comparative studies, reflects the maturation of research methodologies in the field. These developments promise to improve the precision of diagnosis and the effectiveness of treatments.

Despite the challenges inherent in understanding and managing fibromyalgia, the positive sentiment in the research abstracts suggests a research community that remains hopeful and committed to advancing the field. Future research could benefit from focusing on underexplored areas, such as the development of specific biomarkers for fibromyalgia and the exploration of new treatment modalities that address both physical and psychological aspects of the condition.

Our analysis goes beyond identifying trends and themes. It offers a deeper understanding of treatment methodologies and research approaches within the field. Notably, treatment methodologies in fibromyalgia research have shifted markedly—from a predominantly pharmacological focus to more integrative, multimodal strategies. There is a growing emphasis on non-pharmacological interventions, reflecting a broader recognition of the condition’s biopsychosocial complexity.

Concurrently, increased methodological rigor in clinical trials and the adoption of big data analytics have opened new pathways for precision research. As these themes continue to evolve, the next critical frontier involves translating such insights into actionable clinical decision-support tools—particularly those that harness AI to personalize treatment plans for underrepresented populations, such as men and pediatric patients.

Shifts in treatment methodologies

The prominence of terms such as ‘pain’, ‘treatment’, and ‘patient’ suggests a strong focus on patient-centered treatment approaches in fibromyalgia research. Notably, the shift in treatment methodologies over the years can be characterized as follows:

• From pharmacological to multimodal approaches: earlier research primarily concentrated on pharmacological treatments for managing fibromyalgia symptoms. However, recent studies indicate a shift towards multimodal treatment approaches, integrating medication with physical therapy, psychological support, and lifestyle modifications. For instance, Häuser et al. (12) emphasize combining pharmacological and non-pharmacological treatments in managing fibromyalgia.
• Emergence of non-pharmacological therapies: there has been a growing interest in non-pharmacological therapies, such as CBT, exercise, and mindfulness-based stress reduction (MBSR). Glombiewski et al. (13) highlighted their effectiveness in improving the quality of life and reducing symptoms in fibromyalgia patients.

Evolution of research methodologies

The evolution in research methodologies within fibromyalgia studies is reflected in the frequent use of terms like ‘study’, ‘group’, and ‘control’. Key trends include:

• Enhanced rigor in clinical trials: the rigor of clinical trials has improved significantly, with more studies employing RCT designs, as advocated by Fitzcharles et al. (6). This enhancement in study design has contributed to the reliability and validity of research findings.
• Use of big data and machine learning: the application of big data analytics and machine learning in fibromyalgia research is a relatively recent trend. These methodologies allow for the analysis of large datasets to uncover patterns and associations that were previously challenging to detect. A study by Goh et al. (14) illustrates the use of machine learning to identify subgroups within the fibromyalgia patient population, potentially leading to more personalized treatment approaches.
• Interdisciplinary research approaches: recent fibromyalgia research has become increasingly interdisciplinary, integrating insights from neurology, psychology, and genetics. This holistic approach is crucial for understanding fibromyalgia’s multifaceted nature, as Clauw (15) discussed. Researchers are recognizing the need to collaborate across disciplines to gain a comprehensive understanding of the condition.

As shown in Table 2, our study underscores significant trends and transitions in fibromyalgia research, indicating a growing focus on patient-centered strategies and the adoption of sophisticated analytical techniques. These insights point to a shift in research priorities toward more tailored treatment approaches and cutting-edge methodologies. Our analysis also highlighted the role of big data analytics and machine learning in shaping the future of fibromyalgia research. The application of these advanced methodologies has the potential to uncover hidden patterns and subgroups within the fibromyalgia population, ultimately leading to more targeted and effective therapeutic strategies.

Limitations

This study presents valuable insights into the evolving landscape of fibromyalgia research; however, certain limitations warrant consideration. First, the analysis was restricted to PubMed abstracts rather than full-text articles. While abstracts offer a high-level synthesis, they may omit methodological nuances, detailed results, or interpretive context that could enrich topic modeling and sentiment analysis. Future studies could benefit from incorporating full-text corpora to enable a deeper and more granular exploration of research trends.

Second, sentiment analysis, though informative, may oversimplify the tone of scientific discourse, particularly in highly technical or neutral texts. Subtle expressions of skepticism or cautious optimism, common in scientific writing, may be misclassified, thereby affecting sentiment distribution outcomes.

Third, although the LDA model—evaluated with a coherence score of 0.52—yielded interpretable and meaningful topics, the selection of five topics and their thematic interpretation introduce a degree of subjectivity. Future studies could employ automated coherence-based topic selection strategies to fine-tune the number of topics and further enhance interpretability. Additionally, exploring alternative topic modeling approaches, such as non-negative matrix factorization (NMF) or BERTopic, may offer complementary insights and allow for cross-method validation of thematic structures.

Finally, this study emphasizes macro-level patterns. While it identifies key thematic domains and temporal shifts, it does not distinguish between patient populations (e.g., gender, age) or study types (e.g., clinical trials vs. reviews). Consistent with Smith et al. [2022], who highlighted the role of big data in chronic pain stratification, future work could integrate metadata such as authorship networks or publication types to enhance contextual interpretation.

Overall, the methodological framework applied here—particularly the use of coherence scoring to validate topic clusters—marks a step forward in fibromyalgia meta-research. Insights derived from this approach may inform funding priorities and highlight underexplored areas such as pediatric fibromyalgia, male-specific experiences, or emerging non-pharmacological interventions.

Conclusions

In tracing the trajectory of fibromyalgia research through the lens of big data analytics, this study has provided valuable insights into the evolving landscape of fibromyalgia research. Fibromyalgia, characterized by widespread pain, fatigue, and a spectrum of symptoms, has long posed challenges to researchers and clinicians alike. However, integrating big data into medical research has opened doors to a more comprehensive understanding of the condition’s multifaceted nature.

The significance of this study lies in its contribution to the ongoing quest for effective fibromyalgia management strategies. Our study highlights key trends and shifts in fibromyalgia research, suggesting a move towards more patient-centered approaches and the utilization of advanced analytical methods. By providing a comprehensive analysis of research trends, we offer a roadmap for future investigations. As fibromyalgia continues to affect millions worldwide, our data-driven insights aim to guide researchers and clinicians toward more informed decision-making and ultimately improved patient outcomes.

Building upon our findings, several avenues for future research and clinical practice in the field of fibromyalgia can be identified:

• Precision medicine approaches: the identification of patient subgroups with distinct clinical profiles suggests a need for further research into personalized treatment strategies. Future studies could explore the development of predictive models that guide individualized treatment plans, optimizing outcomes for patients with fibromyalgia.
• Exploring mechanisms: the growing focus on the mechanistic understanding of fibromyalgia invites further investigation into the biological underpinnings of the condition. Researchers should delve deeper into the roles of cytokines, genetic polymorphisms, and central sensitization to uncover novel targets for therapeutic interventions.
• Interdisciplinary collaboration: the success of multidisciplinary research in fibromyalgia highlights the importance of collaboration across multiple fields, including neurology, psychology, genetics, and rheumatology. Encouraging cross- disciplinary partnerships can accelerate discoveries and enrich our understanding of the condition.
• Longitudinal studies: given the evolving nature of fibromyalgia research, longitudinal studies are essential to track the impact of emerging treatments and strategies over time. This can help assess their long-term effectiveness and refine clinical guidelines.
• Patient-centered outcomes research: the emphasis on patient-centered research should continue. This approach incorporates patient perspectives into clinical trials and treatment decision-making, ensuring that interventions align with patients’ needs and preferences.
• Ethical considerations: as big data and machine learning play an increasing role in fibromyalgia research, ethical considerations concerning data privacy, informed consent, and bias mitigation become paramount. Future research should address these ethical challenges to maintain trust and integrity in the field.

Acknowledgments

None.

Footnote

Peer Review File: Available at https://jmai.amegroups.com/article/view/10.21037/jmai-24-106/prf

Funding: None.

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://jmai.amegroups.com/article/view/10.21037/jmai-24-106/coif). The author has no conflicts of interest to declare.

Ethical Statement: The author is accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. IRB approval and informed consent are not required as there is no human subject involved in this study.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

References

1. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-10. [Crossref] [PubMed]
2. Raghupathi W, Raghupathi V. Big data analytics in healthcare: promise and potential. Health Inf Sci Syst 2014;2:3. [Crossref] [PubMed]
3. Krumholz HM. Big data and new knowledge in medicine: the thinking, training, and tools needed for a learning health system. Health Aff (Millwood) 2014;33:1163-70. [Crossref] [PubMed]
4. Smith HS, Katz J. Fibromyalgia: An overview. Am J Ther 2014;21:431-8.
5. Phaterpekar T. PubMed Fibromyalgia Article Abstracts Data Set. Kaggle 2019. Available online: https://www.kaggle.com/datasets/tphaterp/pubmed-fibromyalgia-article-abstracts/data
6. Fitzcharles MA, Ste-Marie PA, Goldenberg DL, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag 2013;18:119-26. [Crossref] [PubMed]
7. Yunus MB. Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol 2007;21:481-97. [Crossref] [PubMed]
8. Jiang H, Liu A, Ying Z. Identification of texture MRI brain abnormalities on Fibromyalgia syndrome using interpretable machine learning models. Sci Rep 2024;14:23525. Erratum in: Sci Rep 2025;15:12250. [Crossref] [PubMed]
9. Häuser W, Ablin J, Perrot S, et al. Fibromyalgia. Nat Rev Dis Primers 2015;1:15022. [Crossref] [PubMed]
10. Arnold LM, Clauw DJ, McCarberg BH, et al. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011;86:457-64. [Crossref] [PubMed]
11. Smith JR, Diaz-Perez S, Sterman J, et al. Big Data Analytics for Personalized Medicine: A Case Study on Chronic Pain Management. J Healthc Inform Res 2022;5:50-60.
12. Häuser W, Ablin J, Fitzcharles MA, et al. Fibromyalgia. Nat Rev Dis Primers 2015;1:15022. [Crossref] [PubMed]
13. Glombiewski JA, Sawyer AT, Gutermann J, et al. Psychological treatments for fibromyalgia: a meta-analysis. Pain 2010;151:280-95. [Crossref] [PubMed]
14. Goh J, Le D, Gao J, et al. Machine learning on big data in healthcare. J Big Data 2018;5:29.
15. Clauw DJ. Fibromyalgia: a clinical review. JAMA 2014;311:1547-55. [Crossref] [PubMed]